Rethinking Clinical Trials

MARCH 1, 2023

When we started working on this the discussions with NCI and FDA were about stripping away eligibility, we realized the population would be less controlled than previous studies. We kept coming back to the one thing we want to know, which is the overall survival.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Packaging 130

Rethinking Clinical Trials

MARCH 21, 2023

The intervention arm had to complete weekly PRO survey items from NCI PRO-CTCAE (pain, nausea, vomiting, constipation, diarrhea, dyspnea, insomnia, depression, oral intake). In this study adherence with week ePROs was 91.5%. When patients didn’t report, they received a phone call to make sure they were OK.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Research 130

XTalks

FEBRUARY 27, 2024

According to the National Cancer Institute (NCI), it is estimated that approximately 8,000 people die from melanoma every year in the US. Addressing the high price tag, Iovance’s commercial chief Jim Ziegler said, “Payers have expressed their appreciation for the value proposition for Amtagvi.”

FDA Approval 52

FDA Approval Manufacturing In-Vivo Trials 52

XTalks

AUGUST 17, 2020

Steven Rosenberg and James Yang at the National Cancer Institute (NCI), it has been shown that in adoptive cell therapies, T cells that react to this epitope can have a marked effect on tumor regression and patient benefit, says Dr. Suri. “So Through early work by Drs.

Protein 98

Protein Engineer Immune Response In-Vivo 98

pharmaphorum

OCTOBER 4, 2022

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). As part of the relaunch, a goal was set to reduce the death rate from cancer by at least 50% over the next 25 years.

Biobanking 94

Biobanking Clinical Trials Clinical Trials Trials 94